Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stellbrink

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
HIV Medicine|March 4, 2014
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearanceP Ingiliz, I Krznaric, H-J Stellbrink, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 20, 2001
Phase separation in star-polymer-colloid mixturesJ Dzubiella, A Jusufi, C N Likos, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Genitourinary Medicine|June 1, 1996
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG)H Schöfer, M Imhof, E Thoma-Greber, et al.
Lancet (London, England)|March 20, 2004
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replicationChristoph Hess, Marcus Altfeld, Seddon Y Thomas, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 24, 2014
[Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR']A Kuhlmann, T Mittendorf, M Hower, et al.
AIDS Research and Therapy|October 8, 2008
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOTSarah Kutscher, Claudia J Dembek, Simone Allgayer, et al.
The Journal of Experimental Medicine|September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapyL Zhang, S R Lewin, M Markowitz, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
HIV Medicine|March 4, 2014
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearanceP Ingiliz, I Krznaric, H-J Stellbrink, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 20, 2001
Phase separation in star-polymer-colloid mixturesJ Dzubiella, A Jusufi, C N Likos, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.
Genitourinary Medicine|June 1, 1996
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG)H Schöfer, M Imhof, E Thoma-Greber, et al.
Lancet (London, England)|March 20, 2004
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replicationChristoph Hess, Marcus Altfeld, Seddon Y Thomas, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 24, 2014
[Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR']A Kuhlmann, T Mittendorf, M Hower, et al.
AIDS Research and Therapy|October 8, 2008
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOTSarah Kutscher, Claudia J Dembek, Simone Allgayer, et al.
The Journal of Experimental Medicine|September 8, 1999
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapyL Zhang, S R Lewin, M Markowitz, et al.
Pageof 10